EARLY PSYCHOSIS

Clinical trials for EARLY PSYCHOSIS explained in plain language.

Never miss a new study

Get alerted when new EARLY PSYCHOSIS trials appear

Sign up with your email to follow new studies for EARLY PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 2 Completed 1

Brain drug tested to halt psychosis and protect memory center

Disease control Completed

This study tested whether adding the epilepsy medication levetiracetam (Keppra) to standard antipsychotic treatment could better control symptoms in people with early psychosis. It involved 65 participants aged 16-40 who had been ill for less than 5 years and still experienced sy…

Matched conditions: EARLY PSYCHOSIS

Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

EARLY PSYCHOSIS

Get alerted when new EARLY PSYCHOSIS trials appear

Brain drug tested to halt psychosis and protect memory center